182 related articles for article (PubMed ID: 17187598)
21. Heated humidified high-flow nasal cannula: use and a neonatal early extubation protocol.
Holleman-Duray D; Kaupie D; Weiss MG
J Perinatol; 2007 Dec; 27(12):776-81. PubMed ID: 17855805
[TBL] [Abstract][Full Text] [Related]
22. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
23. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome.
Guilpain P; Auclair JF; Tamby MC; Servettaz A; Mahr A; Weill B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567
[TBL] [Abstract][Full Text] [Related]
24. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
[TBL] [Abstract][Full Text] [Related]
25. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
[TBL] [Abstract][Full Text] [Related]
26. [Health status at the age of 5-7 years of preterm infants with and without bronchopulmonary dysplasia].
Kwinta P; Tomasik T; Klimek M; Cichocka-Jarosz E; Lis G; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):21-6. PubMed ID: 19485251
[TBL] [Abstract][Full Text] [Related]
27. Exposure to oxygen and head growth in infants with bronchopulmonary dysplasia.
Nesterenko TH; Nolan B; Hammad TA; Aly H
Am J Perinatol; 2008 Apr; 25(4):251-4. PubMed ID: 18548401
[TBL] [Abstract][Full Text] [Related]
28. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD.
Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S
Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055
[TBL] [Abstract][Full Text] [Related]
29. Serum eosinophil cationic protein in children with atopic dermatitis.
Murat-Susić S; Lipozencić J; Zizić V; Husar K; Marinović B
Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428
[TBL] [Abstract][Full Text] [Related]
30. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants.
Mohamed WA; Niyazy WH; Mahfouz AA
J Trop Pediatr; 2011 Oct; 57(5):385-8. PubMed ID: 21131270
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables.
Park JH; Choi YL; Namkung JH; Kim WS; Lee JH; Park HJ; Lee ES; Yang JM
Br J Dermatol; 2006 Oct; 155(4):778-83. PubMed ID: 16965428
[TBL] [Abstract][Full Text] [Related]
32. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
[TBL] [Abstract][Full Text] [Related]
33. Respiratory consequences of preterm birth.
Moss TJ
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):280-4. PubMed ID: 16487275
[TBL] [Abstract][Full Text] [Related]
34. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure.
Su PH; Chen JY
J Perinatol; 2008 Feb; 28(2):112-6. PubMed ID: 17989696
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary function in bronchopulmonary dysplasia.
Robin B; Kim YJ; Huth J; Klocksieben J; Torres M; Tepper RS; Castile RG; Solway J; Hershenson MB; Goldstein-Filbrun A
Pediatr Pulmonol; 2004 Mar; 37(3):236-42. PubMed ID: 14966817
[TBL] [Abstract][Full Text] [Related]
36. High expression of pulmonary proteinase-activated receptor 2 in acute and chronic lung injury in preterm infants.
Cederqvist K; Haglund C; Heikkilä P; Hollenberg MD; Karikoski R; Andersson S
Pediatr Res; 2005 Jun; 57(6):831-6. PubMed ID: 15879299
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants].
Hu Q; Lian JM; Li JQ
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):301-3. PubMed ID: 16923362
[TBL] [Abstract][Full Text] [Related]
38. Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia.
Joung KE; Kim HS; Lee J; Shim GH; Choi CW; Kim EK; Kim BI; Choi JH
Free Radic Res; 2011 Sep; 45(9):1024-32. PubMed ID: 21651454
[TBL] [Abstract][Full Text] [Related]
39. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
Ballard PL; Truog WE; Merrill JD; Gow A; Posencheg M; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
Pediatrics; 2008 Mar; 121(3):555-61. PubMed ID: 18310205
[TBL] [Abstract][Full Text] [Related]
40. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.
Capoluongo E; Ameglio F; Lulli P; Minucci A; Santonocito C; Concolino P; Di Stasio E; Boccacci S; Vendettuoli V; Giuratrabocchetta G; De Cunto A; Tana M; Romagnoli C; Zuppi C; Vento G
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E308-13. PubMed ID: 16954333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
